Mortality risk after dementia diagnosis by dementia type and underlying factors: A cohort of 15,209 patients based on the swedish dementia registry

Journal of Alzheimer's Disease

Volumn 41, Issue 2, 2014, Pages 467-477

  Garcia Ptacek, Sara ^a,b   Farahmand, Bahman ^a   Kareholt, Ingemar ^a,c   Religa, Dorota ^a,d   Cuadrado, Maria Luz ^b,e   Eriksdotter, Maria ^a,e  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c JÖNKÖPING UNIVERSITY   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

AGE; AGED; ALZHEIMER DISEASE; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEATH; DEMENTIA; DIFFUSE LEWY BODY DISEASE; FEMALE; FOLLOW UP; FRONTOTEMPORAL DEMENTIA; GENDER; HAZARD RATIO; HUMAN; INSTITUTIONALIZATION; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MORTALITY RISK; MULTIINFARCT DEMENTIA; PARKINSON DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGISTER; SURVIVAL; SWEDISH CITIZEN; EPIDEMIOLOGY; MIDDLE AGED; MORTALITY; PSYCHOLOGICAL RATING SCALE; RISK; SEX DIFFERENCE; SWEDEN; TIME; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; DEMENTIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; REGISTRIES; RISK; SEX FACTORS; SURVIVAL ANALYSIS; SWEDEN; TIME FACTORS;

EID: 84907988175     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-131856     Document Type: Article

References (52)

1. Ganguli M, Dodge HH, Shen C, Pandav RS, DeKosky ST (2005) Alzheimer disease and mortality: A 15-year epidemiological study. Arch Neurol 62, 779-784.
2. Brodaty H, Seeher K, Gibson L (2012) Dementia time to death: A systematic literature review on survival time and years of life lost in people with dementia. Int Psychogeriatr 24, 1034-1045.
3. Wolfson C, Wolfson DB, Asgharian M, M'Lan CE, Ostbye T, Rockwood K, Hogan DB (2001) A reevaluation of the duration of survival after the onset of dementia. N Engl J Med 344, 1111-1116.
4. DeweyME, Saz P (2001) Dementia, cognitive impairment and mortality in persons aged 65 and over living in the community: A systematic review of the literature. Int J Geriatr Psychiatry 16, 751-761.
5. Koller D, Kaduszkiewicz H, van den Bussche H, Eisele M, Wiese B, Glaeske G, Hoffmann F (2012) Survival in patients with incident dementia compared with a control group: A five-year follow-up. Int Psychogeriatr 24, 1522-1530.
6. Steenland K, MacNeil J, Seals R, Levey A (2010) Factors affecting survival of patients with neurodegenerative disease. Neuroepidemiology 35, 28-35.
7. Aguero-Torres H, Fratiglioni L, Guo Z, Viitanen M, Winblad B (1999) Mortality from dementia in advanced age: A 5-year follow-up study of incident dementia cases. J Clin Epidemiol 52, 737-743.
8. Rait G, Walters K, Bottomley C, Petersen I, Iliffe S, Nazareth I (2010) Survival of people with clinical diagnosis of dementia in primary care: Cohort study. BMJ 341, c3584.
9. Lonnroos E, Kyyronen P, Bell JS, van der Cammen TJ, Hartikainen S (2013) Risk of death among persons with Alzheimer's disease: A national register-based nested casecontrol study. J Alzheimers Dis 33, 157-164.
10. Brookmeyer R, Corrada MM, Curriero FC, Kawas C (2002) Survival following a diagnosis of Alzheimer disease. Arch Neurol 59, 1764-1767.
11. Villarejo A, Benito-Leon J, Trincado R, Posada IJ, Puertas-Martin V, Boix R, Medrano MR, Bermejo-Pareja F (2011) Dementia-Associated mortality at thirteen years in the NEDICES Cohort Study. J Alzheimers Dis 26, 543-551.
12. Knopman DS, Rocca WA, Cha RH, Edland SD, Kokmen E (2003) Survival study of vascular dementia in Rochester, Minnesota. Arch Neurol 60, 85-90.
13. Fitzpatrick AL, Kuller LH, Lopez OL, Kawas CH, Jagust W (2005) Survival following dementia onset: Alzheimer's disease and vascular dementia. J Neurol Sci 229-230, 43-49.
14. Roberson ED, Hesse JH, Rose KD, Slama H, Johnson JK, Yaffe K, Forman MS, Miller CA, Trojanowski JQ, Kramer JH, Miller BL (2005) Frontotemporal dementia progresses to death faster than Alzheimer disease. Neurology 65, 719-725.
15. Hanyu H, Sato T, Hirao K, Kanetaka H, Sakurai H, Iwamoto T (2009) Differences in clinical course between dementia with Lewy bodies and Alzheimer's disease. Eur J Neurol 16, 212-217.
16. Aevarsson O, SvanborgA, Skoog I (1998) Seven-year survival rate after age 85 years: Relation to Alzheimer disease and vascular dementia. Arch Neurol 55, 1226-1232.
17. Jellinger KA, Wenning GK, Seppi K (2007) Predictors of survival in dementia with Lewy bodies and Parkinson dementia. Neurodegener Dis 4, 428-430.
18. Bruandet A, Richard F, Bombois S, Maurage CA, Deramecourt V, Lebert F, Amouyel P, Pasquier F (2009) Alzheimer disease with cerebrovascular disease and vascular dementia: Clinical features and course compared with Alzheimer disease. J Neurol Neurosurg Psychiatry 80, 133-139.
19. Barclay LL, Zemcov A, Blass JP, Sansone J (1985) Survival in Alzheimer's disease and vascular dementias. Neurology 35, 834-840.
20. Koedam EL, Pijnenburg YA, Deeg DJ, Baak MM, van der Vlies AE, Scheltens P, van der Flier WM (2008) Early-onset dementia is associated with higher mortality. Dement Geriatr Cogn Disord 26, 147-152.
21. Matsui Y, Tanizaki Y, Arima H, Yonemoto K, Doi Y, Ninomiya T, Sasaki K, Iida M, Iwaki T, Kanba S, Kiyohara Y (2009) Incidence and survival of dementia in a general population of Japanese elderly: The Hisayama study. J Neurol Neurosurg Psychiatry 80, 366-370.
22. Xie J, Brayne C, Matthews FE (2008) Survival times in people with dementia: Analysis from population based cohort study with 14 year follow-up. BMJ 336, 258-262.
23. Rountree SD, Chan W, Pavlik VN, Darby EJ, Doody RS (2012) Factors that influence survival in a probable Alzheimer disease cohort. Alzheimers Res Ther 4, 16.
24. Jagger C, Clarke M, Stone A (1995) Predictors of survival with Alzheimer's disease:Acommunity-based study. Psychol Med 25, 171-177.
25. Stubendorff K, Hansson O, Minthon L, Londos E (2011) Differences in survival between patients with dementia with Lewybodies and patients with Alzheimer's disease-measured from a fixed cognitive level. Dement Geriatr Cogn Disord 32, 408-416.
26. Magierski R, Kloszewska I, Sobow TM(2010) The influence of vascular risk factors on the survival rate of patients with dementia with Lewy bodies and Alzheimer disease. Neurol Neurochir Pol 44, 139-147.
27. Ostbye T, Hill G, Steenhuis R (1999) Mortality in elderly Canadians with and without dementia: A 5-year follow-up. Neurology 53, 521-526.
28. Nourhashemi F, Amouyal-Barkate K, Gillette-Guyonnet S, Cantet C, Vellas B (2005) Living alone with Alzheimer's disease: Cross-sectional and longitudinal analysis in the REAL.FR Study. J Nutr Health Aging 9, 117-120.
29. Religa D, Spangberg K, Wimo A, Edlund AK, Winblad B, Eriksdotter-JonhagenM(2012) Dementia diagnosis differs in men and women and depends on age and dementia severity: Data from SveDem, the Swedish Dementia Quality Registry. Dement Geriatr Cogn Disord 33, 90-95.
30. Wimo A, Religa D, Spangberg K, Edlund AK, Winblad B, Eriksdotter M (2013) Costs of diagnosing dementia: Results from SveDem, the Swedish Dementia Registry. Int J Geriatr Psychiatry 28, 1039-1044.
31. Fereshtehnejad SMRD, Westman E, Aarsland D, Lökk J, Eriksdotter M (2013) Comparison of dementia with Lewy bodies with Parkinson's disease dementia in the Swedish Dementia Quality Registry (SveDem). Neuropsychiatr Dis Treat 9, 927-935.
32. Johnell K, ReligaD, EriksdotterM(2013) Differences in drug therapy between dementia disorders in the Swedish Dementia Registry: A nationwide study of over 7, 000 patients. Dement Geriatr Cogn Disord 35, 239-248.
33. World Health, Organization (1992) The ICD-10 classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines, World Health Organization, Geneva.
34. Socialstyrelsen, Nationella riktlinjer för v°ard och omsorg vid demenssjukdom 2010-stöd för styrning och ledning (2010) (Swedish National Board of Health and Welfare. National Guidelines for Care in Cases of Dementia), http://www.socialstyrelsen.se, Accessed September 25, 2013.
35. SveDem styrgruppen, A° rsrapport SveDem 2011 (2011) (SveDem stirring committee. Yearly report on SveDem 2011). http://www.ucr.uu.se/svedem/index.php/om-svedem/arsrapporter, Updated November 28, 2012, Accessed September 25, 2013.
36. McKeith IG (2006) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the Consortium on DLB International Workshop. J Alzheimers Dis 9, 417-423.
37. Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, Litvan I, McKeith I, Olanow W, Poewe W, Quinn N, Sampaio C, Tolosa E, Dubois B (2007) Clinical diagnostic criteria for dementia associated with Parkinson's disease.Mov Disord 22, 1689-1707; quiz 1837.
38. (1994) Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. J Neurol Neurosurg Psychiatry 57, 416-418.
39. FASS, http://www.fass.se/LIF/startpage?5, Accessed November 28, 2013.
40. Schneeweiss S, Seeger JD, Maclure M, Wang PS, Avorn J, Glynn RJ (2001) Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol 154, 854-864.
41. Rossor MN, Fox NC, Mummery CJ, Schott JM, Warren JD (2010) The diagnosis of young-onset dementia. Lancet Neurol 9, 793-806.
42. Nordstrom P, Religa D, Wimo A, Winblad B, Eriksdotter M (2013) The use of cholinesterase inhibitors and the risk of myocardial infarction and death: A nationwide cohort study in subjects with Alzheimer's disease. Eur Heart J 34, 2585-2591.
43. Henriksson KM, Farahmand B, Johansson S, Asberg S, Terent A, Edvardsson N (2010) Survival after stroke-The impact of CHADS2score and atrial fibrillation. Int J Cardiol 141, 18-23.
44. Williams MM, Xiong C, Morris JC, Galvin JE (2006) Survival and mortality differences between dementia with Lewybodies vs Alzheimer disease. Neurology 67, 1935-1941.
45. Hier DB, Warach JD, Gorelick PB, Thomas J (1989) Predictors of survival in clinically diagnosed Alzheimer's disease and multi-infarct dementia. Arch Neurol 46, 1213-1216.
46. Rockwood K, Wentzel C, Hachinski V, Hogan DB, MacKnight C, McDowell I (2000) Prevalence and outcomes of vascular cognitive impairment. Vascular Cognitive Impairment Investigators of the Canadian Study of Health and Aging. Neurology 54, 447-451.
47. Walker Z, Allen RL, Shergill S, Mullan E, Katona CL (2000) Three years survival in patients with a clinical diagnosis of dementia with Lewy bodies. Int J Geriatr Psychiatry 15, 267-273.
48. Landi F, Gambassi G, Lapane KL, Sgadari A, Mor V, Bernabei R (1999) Impact of the type and severity of dementia on hospitalization and survival of the elderly. The SAGE Study Group. Dement Geriatr Cogn Disord 10, 121-129.
49. Kang SJ, Cha KR, Seo SW, Kim EA, Cheong HK, Kim EJ, Na DL, Jeong JH (2010) Survival in frontotemporal lobar degeneration in a Korean population. Alzheimer Dis Assoc Disord 24, 339-342.
50. Garcin B, Lillo P, Hornberger M, Piguet O, Dawson K, Nestor PJ, Hodges JR (2009) Determinants of survival in behavioral variant frontotemporal dementia. Neurology 73, 1656-1661.
51. Fratiglioni L, Launer LJ, Andersen K, Breteler MM, Copeland JR, Dartigues JF, Lobo A, Martinez-Lage J, Soininen H, Hofman A (2000) Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 54, S10-S15.
52. Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Thies B, Trojanowski JQ, Vinters HV, Montine TJ (2012) National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement 8, 1-13.